Comprehensive medication guide to Haloette including estimated pricing, availability information, side effects, and how to find it in stock at your local pharmacy.
Estimated Insurance Pricing
$0 copay for the covered generic version on most ACA-compliant non-grandfathered plans; brand NuvaRing may require a copay of $10–$50 depending on formulary tier. Some plans require prior authorization.
Estimated Cash Pricing
$85–$199 retail for a 1-month supply (1 ring); as low as $45 with GoodRx or $37–$38 with SingleCare coupons at participating pharmacies. Brand NuvaRing retails higher at $150–$238 per ring.
Medfinder Findability Score
72/100
Summarize with AI
On this page
Haloette is a prescription contraceptive vaginal ring that prevents pregnancy. It is an FDA-approved branded-generic version of NuvaRing, approved in 2022 and manufactured by Mayne Pharma in collaboration with Mithra. It contains two hormones — etonogestrel (a progestin) and ethinyl estradiol (a synthetic estrogen) — embedded in a flexible, soft plastic ring approximately 54 mm in diameter.
Haloette is used by inserting one ring into the vagina for three consecutive weeks (21 days), then removing it for one week. During the ring-free week, a withdrawal bleed similar to a menstrual period typically occurs. A new ring is then inserted to begin the next cycle. Haloette is available by prescription only and is indicated for females of reproductive age.
The ring releases 0.12 mg/day of etonogestrel and 0.015 mg/day of ethinyl estradiol through the vaginal wall via transmucosal absorption. This delivery method achieves effective hormone levels with one of the lowest estrogen doses of any combination hormonal contraceptive on the market.
We have a 99% success rate finding medications, even during nationwide shortages.
Need this medication?
Haloette prevents pregnancy primarily by suppressing ovulation. The synthetic hormones it releases create a negative feedback signal at the hypothalamus and pituitary gland, suppressing the secretion of follicle-stimulating hormone (FSH) and luteinizing hormone (LH). Without these signals, egg development and release (ovulation) are blocked — and without ovulation, fertilization cannot occur.
Secondary mechanisms provide additional protection: etonogestrel thickens cervical mucus, making sperm penetration difficult even in the rare event ovulation occurs. The combined hormones also alter the endometrial lining to discourage implantation. These three complementary mechanisms make Haloette one of the most effective reversible contraceptive methods available, with a perfect-use failure rate of less than 1%.
Unlike daily oral contraceptive pills that produce hormone peaks and troughs, Haloette delivers hormones at a constant rate 24 hours a day. This produces more stable blood hormone levels and is associated with lower rates of nausea compared to oral contraceptives.
0.12 mg/0.015 mg per 24 hours — vaginal ring
Each ring contains 11.7 mg etonogestrel and 2.7 mg ethinyl estradiol; releases 0.12 mg/day etonogestrel and 0.015 mg/day ethinyl estradiol; worn 3 weeks, removed 1 week
As of 2026, Haloette is not listed on the FDA Drug Shortages Database or the ASHP shortage list — there is no declared national shortage. However, localized out-of-stock situations are common because individual pharmacies vary significantly in whether they stock Haloette, EluRyng, or EnilloRing (the three FDA-approved generic rings). Large chain pharmacies (CVS, Walgreens, Walmart) tend to maintain more consistent stock than smaller independent pharmacies.
The findability score for Haloette is 72/100 — generally available, but with minor stocking gaps at individual pharmacies. If you're having trouble finding Haloette, medfinder can call pharmacies near you to find which ones have it in stock, then text you the results.
EluRyng and EnilloRing are FDA-approved bioequivalent alternatives that may be available when Haloette is not. Ask your provider to authorize substitution so your pharmacist can dispense whichever equivalent generic is in stock.
Haloette is not a controlled substance, so any licensed prescriber with prescribing authority can prescribe it in most states without special DEA registration. It is a prescription-only medication requiring a licensed provider to authorize it.
OB/GYNs (most common prescribers for vaginal ring contraceptives)
Family medicine physicians and primary care physicians (PCPs)
Nurse practitioners (NPs) — full prescribing authority in most states
Certified nurse-midwives (CNMs)
Physician assistants (PAs) — under appropriate supervision arrangements
Family planning clinic providers (including Planned Parenthood)
Telehealth options are widely available for Haloette prescriptions in most states. Platforms such as Nurx, The Pill Club, and Wisp can prescribe Haloette or an equivalent generic via video or messaging consultation and ship the medication directly to the patient's door without an in-person visit.
No. Haloette is not a controlled substance and has no DEA scheduling. As a combination hormonal contraceptive, it is classified as a prescription-only medication, but any licensed prescriber with prescribing authority can prescribe it without special DEA registration requirements.
Because Haloette is not a controlled substance, prescriptions can be written for multiple refills (typically up to 12 months' supply), and can be electronically prescribed, faxed, or phoned into a pharmacy without the restrictions that apply to Schedule II–V controlled substances. Mail-order pharmacy and telehealth prescription are also straightforward.
The following side effects occur in 2% or more of users and are generally manageable:
Vaginitis (vaginal infection or irritation)
Headache, including migraine
Mood changes (depression, mood swings, affect changes)
Nausea and vomiting
Vaginal discharge
Weight gain
Breast tenderness or pain
Irregular spotting or breakthrough bleeding (especially first 1-3 months)
Decreased libido
Blood clots (DVT, pulmonary embolism) — leg pain/swelling, shortness of breath, chest pain
Stroke — sudden severe headache, confusion, vision changes, weakness
Myocardial infarction (heart attack)
Toxic shock syndrome (rare) — sudden fever, rash, vomiting, feeling faint
Liver problems — jaundice, severe abdominal pain, dark urine
Severe allergic reaction — hives, difficulty breathing, swelling of face/lips/throat
Know what you need? Skip the search.
EluRyng
FDA-approved generic etonogestrel/ethinyl estradiol vaginal ring by Amneal Pharmaceuticals; identical active ingredients and doses; bioequivalent to Haloette and NuvaRing
EnilloRing
FDA-approved generic etonogestrel/ethinyl estradiol vaginal ring; same hormones and dosing as Haloette; may be stocked at pharmacies where Haloette is unavailable
NuvaRing
Brand-name etonogestrel/ethinyl estradiol vaginal ring by Advanz Pharma; same hormones as Haloette; typically higher retail cost ($150-$238 per ring)
Annovera
Year-long vaginal ring (segesterone acetate/ethinyl estradiol) by TherapeuticsMD; same 3-weeks-in/1-week-out schedule; lasts 13 cycles; good for patients who want to reduce monthly pharmacy visits
Nexplanon
Etonogestrel subdermal implant lasting 3 years; same progestin as Haloette but no estrogen; ideal for patients who cannot use estrogen or want long-acting protection
Prefer Haloette? We can find it.
St. John's Wort
majorStrong CYP3A4 inducer; significantly reduces etonogestrel and ethinyl estradiol blood levels; can cause contraceptive failure. Avoid concurrent use or use reliable backup non-hormonal contraception.
Rifampicin / Rifabutin
majorPotent CYP3A4 inducers used for tuberculosis; markedly reduce ring efficacy. Use non-hormonal contraception during treatment and for 28 days after.
Phenytoin, carbamazepine, phenobarbital, oxcarbazepine, topiramate
majorAnticonvulsants that induce CYP3A4; reduce Haloette's contraceptive efficacy. Use backup non-hormonal contraception and consider discussing alternative contraceptive methods with provider.
Ombitasvir/paritaprevir/ritonavir (Viekira Pak, Technivie)
majorContraindicated. This HCV combination causes ALT elevations >5x ULN in women using ethinyl estradiol products. Discontinue Haloette before starting and wait at least 2 weeks after completing this regimen.
Vaginal miconazole nitrate (intravaginal)
moderateCYP3A4 inhibitor via vaginal route; increases etonogestrel and ethinyl estradiol concentrations by 17-40%. Does not require discontinuing Haloette but may intensify hormonal side effects.
Grapefruit / grapefruit juice
moderateCYP3A4 inhibitor in intestines; may increase hormone levels and side effects. Avoid grapefruit products while using Haloette.
HIV protease inhibitors and NNRTIs
moderateVariable CYP3A4 effects; can increase or decrease hormone levels unpredictably. Consult both HIV specialist and contraceptive provider for personalized guidance.
Haloette offers patients the same proven contraceptive protection as brand-name NuvaRing at a significantly lower cost. As one of three FDA-approved generic etonogestrel/ethinyl estradiol vaginal rings, it benefits from expanded supply resilience compared to the days when NuvaRing was the only option. For most patients with ACA-compliant insurance, Haloette or an equivalent generic is available at $0 copay.
The main challenge patients face is not cost but availability at their specific local pharmacy. Individual pharmacies stock Haloette inconsistently, and stock-outs can occur even without a national shortage. Requesting refills 7-10 days early, asking your provider to write for the generic class with substitution permitted, and using a mail-order pharmacy are the most effective ways to avoid access gaps.
If you're struggling to find Haloette at a pharmacy near you, medfinder can call nearby pharmacies on your behalf to identify which ones have it in stock and text you the results — saving you the time and frustration of calling around yourself.
Medfinder Editorial Standards
Our medication guides are researched and written to help patients make informed decisions. All content is reviewed for accuracy and updated regularly. Learn more about our standards
ChatGPT
Claude
Perplexity
Grok
Gemini